Fingerprint
Dive into the research topics where Epie Boven is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer
Bhin, J., Yemelyanenko, J., Chao, X., Klarenbeek, S., Opdam, M., Malka, Y., Hoekman, L., Kruger, D., Bleijerveld, O., Brambillasca, C. S., Sprengers, J., Siteur, B., Annunziato, S., van Haren, M. J., Martin, N. I., van de Ven, M., Peters, D., Agami, R., Linn, S. C. & Boven, E. & 4 others, , 2023, In: Journal of experimental medicine. 220, 11, e20211743.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile36 Downloads (Pure) -
Pertuzumab Plus Trastuzumab with or Without Chemotherapy Followed by Emtansine in ERBB2 -Positive Metastatic Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial
Huober, J., Weder, P., Ribi, K., Thürlimann, B., Thery, J.-C., Li, Q., Vanlemmens, L., Guiu, S. V., Brain, E., Grenier, J., Dalenc, F., Levy, C., Savoye, A.-M., Müller, A., Membrez-Antonioli, V. R., Gérard, M.-A., Lemonnier, J. R., Hawle, H., Dietrich, D. & Boven, E. & 1 others, , 19 Oct 2023, In: JAMA oncology. 9, 10, p. 1381-1389 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer
Bos, M. K., Lam, S. W., Motta, G., Helmijr, J. C. A., Beaufort, C. M., de Jonge, E., Martens, J. W. M., Boven, E., Jansen, M. P. H. M., Jager, A. & Sleijfer, S., Jul 2023, In: Breast cancer research and treatment. 200, 2, p. 271-279 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile16 Downloads (Pure) -
Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib
Diekstra, M. H. M., Swen, J. J., van der Zanden, L. F. M., Vermeulen, S. H., Boven, E., Mathijssen, R. H. J., Fukunaga, K., Mushiroda, T., Hongo, F., Oosterwijk, E., Cambon-Thomsen, A., Castellano, D., Fritsch, A., Donas, J. G., Rodriguez-Antona, C., Ruijtenbeek, R., Radu, M. T., Eisen, T., Junker, K. & Roessler, M. & 6 others, , 1 Jun 2022, In: Cancers. 14, 12, 2838.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile17 Downloads (Pure) -
Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes
Kruger, D. T., Opdam, M., Sanders, J., van der Noort, V., Boven, E. & Linn, S. C., 1 Apr 2020, In: APMIS. Acta pathologica, microbiologica et immunologica Scandinavica. 128, 4, p. 298-307 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile15 Downloads (Pure)